HIGHLIGHTS
- who: Fenglin Li et al. from the Department Hematology, The Affiliated People`s Hospital Ningbo University, Ningbo, China have published the article: Characterization of the Newly Established Homoharringtonine- (HHT-) Resistant Cell Lines and Mechanisms of Resistance, in the Journal: Journal of Oncology 40 of 30/08/2022
- what: The main reasons for poor prognosis in AML patients are primary drug resistance and disease relapse. Based on the above-mentioned background, the authors aimed to establish HHT-resistance AML cell lines with different RIs via exposure to gradually increasing HHT concentrations. The authors focused on upregulated . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.